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Abstract
Background: Conventional diagnosis of malaria has relied upon either clinical diagnosis or microscopic examination of
peripheral blood smears. These methods, if not carried out exactly, easily result in the over- or under-diagnosis of
malaria. The reliability and accuracy of malaria RDTs, even in extremely challenging health care settings, have made
them a staple in malaria control programmes. Using the setting of a pilot introduction of malaria RDTs in Greater
Garissa, North Eastern Province, Kenya, this study aims to identify and understand perceptions regarding malaria
diagnosis, with a particular focus on RDTs, and treatment among community members and health care workers (HCWs).
Methods: The study was conducted in five districts of Garissa County. Focus group discussions (FGD) were performed
with community members that were recruited from health facilities (HFs) supported by the MENTOR Initiative. In-depth
interviews (IDIs) and FGDs with HCWs were also carried out. Interview transcripts were then coded and analysed for
major themes. Two researchers reviewed all codes, first separately and then together, discussed the specific categories,
and finally characterized, described, and agreed upon major important themes.
Results: Thirty-four FGDs were carried out with a range of two to eight participants (median of four). Of 157
community members, 103 (65.6%) were women. The majority of participants were illiterate and the highest level
of education was secondary school. Some 76% of participants were of Somali ethnicity. Whilst community members
and HCWs demonstrated knowledge of aspects of malaria transmission, prevention, diagnosis, and treatment,
gaps and misconceptions were identified. Poor adherence to negative RDT results, unfamiliarity and distrust of
RDTs, and an inconsistent RDT supply were the main challenges to become apparent in FGDs and IDIs.
Conclusion: Gaps in knowledge or incorrect beliefs exist in Greater Garissa and have the potential to act as barriers to
complete and correct malaria case management. Addressing these knowledge gaps requires comprehensive education
campaigns and a reliable and constant RDT supply. The results of this study highlight education and supply chain as
key factors to be addressed in order to make large scale roll out of RDTs as successful and effective as possible.
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Background
Despite being preventable and treatable, malaria con-
tinues to be a life-threatening disease resulting in high
levels of morbidity and mortality. Malaria is estimated to
cause between 660,000 and over a million deaths every
year and in 2012 there were an estimated 207 million
cases of malaria [1]. Worldwide estimated malaria mor-
tality rates between 2000 and 2012 fell by 42% across all
age groups and by 48% amongst children under five
years old [2]. However, the pace of this decrease slowed
between 2011 and 2012 [2]. Current day malaria cases
and deaths are indicative of a lack of access to indoor
residual spraying (IRS) and long-lasting insecticidal nets
(LLINs) using effective insecticides, and artemisinin-
based combination therapy (ACT) amongst millions of
people currently at risk of malaria.
Malaria diagnosis
Until recently, conventional diagnosis of malaria has
relied upon either clinical diagnosis or microscopic
examination of peripheral blood smears [3]. These diag-
nostic methods require trained staff, expensive and fragile
equipment, and, in the case of microscopy, an electricity
supply. These requirements and the intrinsic potential
for human or technical error have been shown to result
in patients who do not have clinical malaria being diag-
nosed as positive and prescribed anti-malarials [3-7].
This over-diagnosis of malaria and the resultant anti-
malarial treatment is a waste of resources in often
resource-scarce settings, exposes patients to needless
anti-malarial therapy, likely contributes to the develop-
ment of drug resistance, and may compromise patient
trust in health care providers as their condition does
not improve upon treatment [8,9]. The problem of
misdiagnosis and over (and under) treatment of malaria
provided the impetus for the development of a more
reliable, field-suitable, and cost effective diagnostic tool
[10,11]. The malaria rapid diagnostic test (RDT) is the
current diagnostic tool which best meets these criteria.
In 2010 the WHO recommended that all suspected
cases of malaria be confirmed with a diagnostic test
prior to treatment [12].
Based on the detection of Plasmodium antigens in a
small drop of the patient’s blood, these tests are easy to
use (requiring only minimal training of health workers).
As the name suggests, the result is given almost instantly
and is easy to interpret. The accuracy of these tests
varies between brands and between location and epi-
demiological setting, however, on the whole the tests
have very high levels of sensitivity and specificity and
also high negative-predictive values [13,14]. The reliabil-
ity and accuracy of RDTs, even in extremely challenging,
remote settings where infrastructures may be broken,
health care systems weak and education poor, have made
them a staple in malaria control programmes and the
first choice malaria diagnosis tool, especially when
microscopy is not possible, or suitable [2,12].
Despite the ease of use and interpretation of RDTs,
barriers to their correct use and subsequent results-
based treatment remain. A study in southeast Nigeria
found that health care workers (HCWs) reported per-
ceiving RDTs as a more effective malaria diagnosis tool
than both microscopy and clinical diagnosis, however,
some providers experienced difficulties in using the
kits and ACT was prescribed to 74% of RDT-negative
patients [15]. A similar study in primary health facilities
(HFs) in Uganda reported high levels of uptake with more
than 90% of eligible patients offered an RDT; there was
also a 38% point reduction in anti-malarial prescriptions.
Of HCWs interviewed it was reported that 92% believed
a positive RDT confirmed malaria, whereas only 49%
believed that a negative RDT result excluded malaria
infection [16]. Given the high negative predictive value
of RDTs, the perception of negative test results not
being reliable is a misconception and a hindrance to
appropriate treatment.
Studies in to the attitudes and beliefs of health care
providers and patients surrounding malaria diagnosis,
and RDTs in particular, hope to understand why this
misconception, and others of its type, persist. Knowledge
and understanding of these barriers to the uptake and
correct usage of RDTs aid in overcoming them and im-
proving malaria case management. A study in Nigeria
found that providers and community members both rec-
ognized malaria RDTs as an important step to correct
treatment, however, it was also reported that there were
concerns as to the reliability of test results with symp-
toms being deemed more important than test results
[17]. A similar study in Uganda looked at the introduc-
tion of RDTs in to registered drug shops and also found
a mistrust of negative RDT results. Factors reported to
reduce the appeal of RDTs included the cost of the test
and the extra time required to be tested [18].
RDTs in Kenya
In 2010 the Department of Malaria Control, Ministry of
Public Health, Kenya, and the MENTOR Initiative
launched the official introduction of RDTs in 42 HFs in
Greater Garissa and the districts it contained at the time:
Garissa, Lagdera, Fafi, and Balambala. This programme
complemented the Ministry of Health programmes supply-
ing ACT to HFs and was intended to both reduce irrational
AL consumption and improve prescription practises. The
total numbers of confirmed malaria cases and artemether-
lumefantrine (AL) treatments distributed between 2010
and 2013 are shown in Figure 1 (Garro C: Evaluation Re-
port; Building Sustainable and Effective Malaria Control for
Vulnerable Communitis in Kenya, unpublished); total
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malaria cases are separated into those diagnosed by RDTs
and those diagnosed by microscopy. As the number of
RDTs increased in HFs in 2011, there was a marked and
rapid decrease in the total number of confirmed cases, the
number of microscopy confirmed cases, and the number of
AL treatments dispensed. By 2013, the increasing uptake
and usage of RDTs in HFs was evident from the number
of RDT-diagnosed cases, which was higher than the num-
ber of microscopy-diagnosed cases. Reflecting the reduc-
tions in total confirmed cases, the total number of AL
doses dispensed in 2013 was at a four-year low of 4,519
treatments, down from the peak of 56,511 treatments
dispensed in 2011.
Aim of this study
Knowledge of community members’ and HCWs’ thoughts
and opinions on RDTs is vital; it is the aim of this study to
understand perceptions towards RDTs and how these affect
RDT use, subsequent HCW prescription practises, and pa-
tient adherence and behaviour. Results of this kind will be
vital in improving the uptake and usage of RDTs in similar
contexts in Greater Garissa and other counties of Kenya.
Methods
Study area and population
Garissa is home to an estimated 623,060 people, over
90% of which are ethnic Somali Kenyans, many of whom
are nomadic pastoralists, living in an area of 44,175 sq km
[19]. According to the last demographic health survey, the
literacy rates in North Eastern Province are the lowest in
Kenya at 21% for women and 64% for men [20]. The
county has, for the last 20 years, hosted the world’s largest
refugee camp, which by 2013 contained an estimated
596,000 refugees, largely from neighbouring Somalia [21].
The study was conducted in the four original districts
of Garissa County: Garissa, Balambala, Lagdera, and Fafi,
to which Dadaab was subsequently added (Figure 2). The
area suffers regular rebel attacks and is generally very inse-
cure [22,23]. The study area is prone to malaria epidemics
[24]. Immunity is low due to infrequent exposure to infec-
tion during the early years of childhood and the occur-
rence of seasonal, severe flooding resulting in sudden
increases in mosquito populations. In areas such as these
with typically seasonal epidemics the community is often
highly aware of the threat of malaria and in many cases
both communities and health workers have come to
associate all fevers with malaria despite the fact that
outside of the rainy season malaria is a very minor cause
of febrile illness [25]. Many other diseases (bacterial,
viral, parasitic) which present with fever commonly
occur in the same area [26-29].
In this area, the MENTOR Initiative provides malaria
services in partnership with the Ministry of Public
Health. The study was performed by the MENTOR Ini-
tiative as part of a quality assurance assessment and the
continual process of monitoring and evaluation.
Study design
HFs (all outpatient facilities) were selected using purpos-
ive and criteria sampling technique as well as probability
sampling. Due to chronic security issues and lack of
accessibility during the study periods, five of the HFs
were not included; a total of 12 HFs were sampled from
a maximum of 42 facilities in the area. Six were chosen
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Figure 1 The total numbers of malaria cases and numbers of artemether lumefantrine treatments distributed. Total number of AL
treatments dispensed, confirmed malaria cases (microscopy and RDT), microscopy confirmed cases, and RDT confirmed cases across the study
area between 2010 and 2013 and broken down in to yearly quarters (except 2010 data which was only collected over the period between
September and December).
Diggle et al. Malaria Journal 2014, 13:502 Page 3 of 12
http://www.malariajournal.com/content/13/1/502
on the basis of whether or not they were accessible, and
their rates of over-prescribing ACT (defined as more
than 2.5%) versus six with good prescription habits,
defined as ACT over-prescription rates below 2.5%
(according to data collected by the MENTOR Initiative
from May 2011 to July 2013). However, due to security
issues the health facilities also had to be sampled based
on accessibility. HFs in an area deemed to be insecure or
inaccessible were not visited.
Prior to data collection, five pilot evaluations and discus-
sions with local key informants were used to highlight key
issues and to make sure they were covered in study inter-
views. These interviews were used to help probe questions
and areas of focus, and to ensure the cultural adaptability,
reliability, and validity of the study design and questions.
The interview tools were informed based on a previous
study in the Mandera region of Kenya [31] and subsequent
pilot evaluations performed during ongoing implementation
Figure 2 Map of the study area. A map of the study area of Greater Garissa, North Eastern Province, Kenya [30].
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of the MENTOR services/programme over several months
prior to the study implementation. This pilot evaluation
included informal discussions with local key informants
and was used to highlight key issues to be covered in
study interviews.
FGDs and interviews were held at HFs, held separately
for each group of participants and were conducted
mostly in Somali (the most commonly used language) with
some in Swahili, and using trained interpreters or English
when applicable. FGDs and IDIs were tape-recorded and
written notes were taken on non-verbal communication
during interviews. Active discussion and interaction among
participants was encouraged. Participants were asked a
series of open-ended questions with subsequent probes
and follow-up questions as needed. The decision to choose
FGDs over individual interviews for community members
was based on input from community leaders and local
informants. A mixture of male and female interviewers
originally trained as either clinical officers, CHWs or
pharmacist and trained in how to conduct the inter-
views for this study by ED conducted the interviews
over a period of 17 days. The sex of the interviewer was
always the same as the sex of the interviewee.
The selection criteria of participants varied depending
on the data collection method and the type of participants.
Key informants were defined as persons positioned to
possess knowledge of particular relevance to the re-
search themes, including community health workers
(CHWs), medical providers, religious figures, and commu-
nity leaders who were working or living in the catchment
area for this study. Community member participants were
selected from patients aged 18 years or older, with a febrile
illness, who presented to HFs on the date of the interview.
Fever status was defined if recorded in the medical record
(either reported by patient or measured by HCW). Both
male and female subjects were included. HCWs (n = 65)
from the same HF were invited to participate and key
informants were selected using criteria sampling tech-
nique including different occupations, religious back-
grounds, age groups, and gender.
FGDs were performed with community members
recruited from healthcare centres supported by the MEN-
TOR Initiative, as were in-depth interviews (IDIs). FGDs
with patients explored their understanding of malaria
causes, transmission, signs and symptoms, diagnosis,
diagnostic tools, and treatment. IDIs with HCWs explored
their perspectives and experiences of using malaria diag-
nostic tools, including RDTs, prescription and treatment
practises, and experience with patients. Additionally,
interviews with key informants were conducted.
Ethical approval
Oral consent was obtained, and participants were in-
formed that their participation would have no impact on
their treatment or affect them otherwise, and that they
could retract their responses and/or participation at any
time. Ethical approval was obtained from the Kenyatta
National Hospital and the University Of Nairobi College
Of Health Sciences (P624/11/2012).
Analysis
Interview transcripts were coded and analysed for major
themes. Coding of transcripts was done using Excel and
through open, axial and selective coding. More than 600
pages of transcripts were analysed and around 190 codes
were developed. Codes fell into distinct but overarching
categories. Patterns in responses and codes were analysed
to explore and develop relevant themes. Observational
data, including setting and non-verbal communication,
were collected and noted in order to enhance analysis.
Inductive grounded theory process for analysis was
applied. During content analysis preliminary coding was
developed based on priority codes derived from the the-
oretical framework and conceptual model guiding the
study. Critical deliberation was performed about initial
coding and reviewed coding for similarities and varia-
tions among coders’ output. Discrepancies were dis-
cussed and a high level of agreement was achieved,
suggesting that the coding scheme used was appropri-
ate. Two researchers independently reviewed all codes,
then met and reviewed codes, discussed the specific cat-
egories, used inputs as needed, and finally characterised,
described, and agreed upon major important themes.
Results
Demographics of study population
A total of thirty-five FGDs were carried out with a range
of two to eight participants (median of four), thirty-four
of these FGDs were with patients, and one was with
HCWs (Table 1). Of the 157 community members, 103
(65.6%) were women. The youngest participant was 18 years
old and eight participants were above the age of 50. The
majority of participants were illiterate and the highest
level of education was secondary school. Some 76% of
participants were ethnic Somali. Of the female community
participants the overwhelming majority were reported to
be housewives. The full demographics of key informants
and HCWs are presented in Table 2.
Community members
Overarching themes surfaced from FGDs relating to
general knowledge about transmission, symptoms, treat-
ment, expectations of diagnostic and treatment methods,
treatment adherence, and medication taking practices.
General knowledge about malaria and transmission
Community member participants had varying levels of
understanding about the causes of malaria. The majority
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of participants understood mosquitoes to be at least
one cause of malaria, but most did not correctly identify
the pathway of transmission. Other attributed causes
included water, food (mangoes in particular), milk, dirt,
poor hygiene, and exposure to someone who has malaria
(via breathing/sharing rooms).
“Drinking dirty water causes malaria”
(FGD B1, R4).
“[Children] will get through their breath if they sleep
together” (FGD M3 R3).
Some participants believed malaria could be caused by
various other illnesses, such as a cold that has worsened,
or generalized “excess bile”.
“Malaria is caused by being sick severely and not
visiting health facility” (FGD B1, R2)
“We just know bile to be the cause of malaria not as
in hospitals…. describe it” (FGD B3 R2).
Alternatively, malaria itself was said to cause other
illnesses.
Table 1 Data collection methods and participants
involved
Data collection
method (n)
Participants (n)
FGD (1) HCWs (8)
FGD (34) Patients (157)
IDI (23) HCWs (23)
KI interviews (27) CHWs, medical providers, religious
figures, community leaders (27)
Summary information of the data collection methods used and the numbers
and types of participants involved.
Table 2 Demographics of health care workers and key community informants
Health care workers No. % (Total = 23) Key informants No. % (Total = 27)
Profession
Clinical officer 4 17.4 Cultural Leaders (Imam and Village Elder) 3 11.1
Nurse 9 39.1 Group Leaders (youth, women’s group, community information
officer, prison leader, school teacher, college student)
10 37.0
Laboratory technician 9 39.1 Administrative Health Key Informants (Chairman Health Centre,
Hospital Committee Member)
3 11.1
Pharmacist 1 4.3 Other health worker (community health workers) 6 22.2
Service industry (business man, tea vendor, private pharmacy
owner, chairman water project)
5 18.5
Age
30 and under 15 65.2 30 and under 13 48.1
31-41 8 34.8 31-41 10 37.0
42-51 0 0 42-51 3 11.1
Ethnicity/tribe
Somali 1 4.3 Somali 20 74.0
Other 20 87.0 Other 6 22.2
Unknown 2 8.7 Unknown 1 3.7
Gender
Female 8 34.8 Female 7 25.9
Male 15 65.2 Male 20 74.0
Years of professional training Level of education
3 years and above 23 100 Illiterate 4 14.8
Fewer than 3 years 0 0 Primary School dropout 7 25.9
Primary School complete 3 11.1
Secondary School dropout 7 25.9
Secondary School Leaver 4 14.8
Diploma 1 3.7
Unknown 1 3.7
Demographic information, including the profession, age, ethnicity/tribe, gender, and years of professional training, separated for health care workers and
key informants.
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“Malaria is the starting point of all disease…after that
everything else changes to other diseases” (FGD B3 R1)
Among participants who connected mosquitoes with
malaria, some discussed the use of nets, and neglecting
to use them properly as a way to get malaria. Generally,
participants mentioned more than one cause, and there
was a wide range of responses. Nets were discussed as a
means of prevention, as were other methods, such as
showering after a mosquito bite.
“Take shower early in the morning after mosquito bite
at night to prevent malaria….the blood is not circulated
at night and the mosquito bites at night……the malaria
is not transferred into the blood yet” (FGD B4 R3).
Malaria symptoms and treatment
Regarding malaria symptoms, responses were quite gen-
eral, although some participants did state that malaria
could be differentiated from other fevers and illnesses.
“The strongest fever it’s for malaria” (FGD M6 R4)
“I know myself if I have malaria, I will feel dizziness”
(FGD GKP5 R3)
Symptoms commonly identified included fever, chills,
body aches, headaches, joint pain, weakness, appetite
loss, fatigue, and a cough. Most participants acknowl-
edged that fever and many of these symptoms may come
from other diseases (typhoid, whooping cough, tubercu-
losis, pneumonia, etc.).
Seeking treatment right away versus after a few to sev-
eral days of alternative therapy depended on how close
or accessible the hospital or health centre was. Partici-
pants who lived closer to the hospital responded that
“immediately I become sick that is when I come to
hospital” (FGD M6 R8).
While others noted that they go to the treatment facility
“only when I have the money and time to visit”
(FGD Me4 R2).
“People who live in rural areas… don’t visit the facility
right away when they’re sick but after 7 days… some
become critical… then they are brought the facility by
donkey cart or camel… [or] car” (FGD B2 R1).
Expectations of diagnostic and treatment methods
Almost all participants were familiar with microscopy
and RDT, although many had not actually seen these
tools used, and some noted scepticism.
“I don’t believe that one… microscope” (FGD M3 R3).
“I will not believe that [negative diagnosis if child
presents with symptoms]” (FGD M3 R1).
A few participants noted a preference of one method
over the other. However, when discussing malaria diag-
nosis, more participants said they wanted malaria treat-
ment, even in the case of a negative diagnosis by either
RDT or microscopy.
“I will like him to give me ACT [when testing negative
for malaria]” (FGD B1 R4).
“But I still have malaria….am having loss of appetite”
(FGD B1 R2).
“Sometimes some of us insist that the doctor treats us
for the same malaria that was negative” (FGD If6 R1).
A common response when asked why they still wanted
the treatment in light of a negative diagnosis was that
malaria medication
“will cure the joint pain” (FGD B1 R4).
Some participants acknowledged that this was a perva-
sive attitude in the community, and pointed out that
diagnosis is important and should be trusted. Some also
talked about how attitudes towards testing are changing,
and that RDT is becoming more accepted and encour-
aged. Nonetheless, its resemblance to HIV testing kits
poses a problem, as some patients fear they are being
tested for HIV, or they believe it is not the right test.
“I prefer microscopy because RDT I don’t know whether
they are testing HIV or something else” (FGD GKP4 R1).
Despite some changing attitudes, there is still resistance in
the community to accepting negative diagnosis, with pa-
tients diagnosed as negative getting malaria medication ei-
ther from friends/relatives or from private pharmacy shops.
“If he doesn’t give me, I will just buy” (FGD GKP5 R3).
Participants recounted that it is common to expect a
positive diagnosis, and to not accept or trust a negative
RDT result. Local pharmacy shops make it easy to ob-
tain malaria treatment, and make it available by request
(without use of RDT or microscopy).
“If [test at hospital] tells you are negative maybe there
is possibility of the instrument he is using might be
faulty” (FGD If4 R1).
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Participants were aware of the different types of treat-
ment available for malaria. Alternative therapy was also
discussed. These included the use of neem tree leaves,
camel’s milk, aloe vera, and other methods. Attitudes
towards medication adherence, once malaria treatment
is prescribed, were inconsistent. A common response
was stopping treatment once one would feel better
“I stop [the medication] when he [the child] is fine”
(FGD B5 R2)
in order to save the rest of the medication for another
time, or to share with a relative or friend if they think
they have malaria.
“I ask her of the sign and symptoms and they are same
as mine then I will share it with her” (FGD GKP5 R2).
Another reason for non-adherence was simply that taking
the medication was unpleasant or too cumbersome when
taking too many pills at a time. Several respondents pointed
out that they wished for extra medication due to the diffi-
culties of getting to the health centre in the future.
“If you are not living near dispensary you would wish
the doctor to give you excess so that you give your
children since you are not be able to come another
time” (FGD M3 R3).
Health care workers
General perceptions of RDTs and microscopy
General themes circled around advantages and disad-
vantage of RDTs and microscopy, patient pressure and
treatment expectations despite negative test results,
issues of adherence, lack of consistent supplies, and the
importance of patient health education. HCWs gener-
ally found both microscopy and RDT as effective tools
for malaria diagnosis, each with their own advantages
and disadvantages. The RDT was noted for its ease and
swiftness of use, portability and non-reliance on electri-
city. Microscopy, for its familiarity, ability to provide
more information about the infection and opportunity to
discern the organisms present or identify other illnesses.
“[With microscopy] you can really see with your eyes
that this is a real parasite if you are somebody really
trained” (DHMT R4).
However, microscopy requires a higher level of train-
ing, and is subject to the skill of the technician more
than RDTs.
“All health workers can [use] RDTs… it’s a procedure
that anybody can perform. Unlike the microscopy
whereby we only have the lab technician to perform it.
RDT is simple” (IDI R7).
Notably, when discussing the different diagnostic
tools, health workers consistently pointed out that use
of tools is subject more to availability and access than
provider preference. They elaborated on inconsistent
supply, resulting in RDTs not always being available for
testing. They also noted a level of scepticism towards
RDTs, both among patients and clinic staff, due to
their surprising high rate of negative results, as com-
pared with what both patients and providers were used
to seeing when only symptoms were used for diagnosis.
“If the RDT turns negative and you still see this patient
has those signs of malaria is better that you send that
patient for microscopy for further testing” (IDI R9).
Provider-patient interactions
With regard to patient reactions to and expectations
of diagnosis, two major themes emerged. It was widely
reported that patients do have expectations of being
treated for malaria regardless of diagnostic result.
“Whenever you test and you find malaria is negative,
you find that person is not satisfied” (IDI R2).
Most HCWs discussed how this is highly prevalent
and problematic in their community, and how providers
in the past have overprescribed malaria treatment in part
due to these expectations.
“They believe that every fever is malaria regardless…
Even us whenever we used to have fever we used to
think it is malaria but when we do RDT, it is negative”
(IDI R1).
At the same time, most noted the role of the provider to
educate the patient, and reported good outcomes from
taking the time to speak with patients and explain to them
how malaria is transmitted, how testing works and the
possibility of other illnesses causing their symptoms. They
reported positive experiences when they tried
“to make [patients] understand that not all the fever…
to be malaria. We counsel before the test, and tell
them, let us [perform] test…but it can be negative, it
can be positive. So if it is negative it doesn’t mean you
don’t have any problem… but we have to rule out
malaria first…and they appreciate, they really
appreciate” (IDI R2).
HCWs discussed their impressions of community
perspectives. Many patients they see think that fever
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automatically means malaria, if not all year, then in certain
seasons when malaria is perceived to be more prevalent.
They discussed community misconceptions about trans-
mission, such as food sources and drinking dirty water.
The community does not trust RDTs enough, particularly
when they see a negative diagnosis.
“When you test… they will start even laughing and
they will say I know it will still come negative so there
is no need for you to test” (IDI R3).
Health workers reported that patients often either
insist on being given malaria medication, or they go to
their local shops where they can purchase malaria
medication anyway (without diagnosis). They also dis-
cussed problems with adherence, and practices such as
splitting up medication with relatives or friends, or
saving half of their treatment course for another time.
Suggestions for improvement
Moving forward, health workers emphasized that pa-
tients and the community at large need to be educated
about malaria, its transmission, diagnosis, and treatment,
as well as about other febrile illnesses.
“I think again there is need for mobilization so that we
can provide health education to them so that they can
know what really causes malaria not just, oh, the child
has fever” (IDI R18).
Additionally, they discussed the issue of resources. While
education and health promotion is important in facilitating
community attitudes, they also pointed out that supplies of
both diagnostic tools and treatment/medication must be
consistent.
“You know like right now we have … some days we
run out [of supplies]” (IDI R3).
Health providers also discussed continued training needs,
particularly in diagnostic methods such as microscopy.
Discussion
The study and results presented here explore the thoughts
and opinions of both community members and HCWs in
relation to RDTs in Greater Garissa, which have only been
available relatively recently. It is of particular interest and
importance to investigate perceptions towards RDTs in
this area, and over the initial period of national scale-up.
As part of the nationwide rollout of RDTs in Kenya, the
President’s Malaria Initiative and the Global Fund pro-
cured a total of 8.6 million RDTs in September 2012 for
use in dispensaries and HFs. At the baseline measurement
in 2010 only 8% of HFs had RDTs, compared to the 31%
stocking the tests in 2012 [32]. In order to make this
continuing national scale-up as effective as possible in
improving malaria diagnosis and treatment, studies
such as this one are vital in understanding context-
specific challenges that may compromise uptake and
usage of RDTs.
The main findings of this study were that there are a
number of misconceptions regarding malaria transmis-
sion, diagnosis, prevention, and treatment. Participants
reported that malaria can be transmitted via food or
drink products and via the air. There is an obvious gap
in the knowledge of the community with regard to mos-
quitoes as the vector of transmission. This lack of infor-
mation or understanding is also present when discussing
malaria prevention methods; one participant reported
that a morning shower could prevent malaria infection.
On the other hand, it is encouraging that there is a
general knowledge of the non-specific symptoms of
malaria as well as an appreciation of the ability of other
organisms to bring about these symptoms. A basic
knowledge by community members of transmission and
prevention of malaria is integral to ensuring an appreci-
ation of the need for confirmatory diagnosis before the
prescription of anti-malarials, and, in turn, a respect for
the result of the RDT test and the following anti-malarial
prescription or referral.
Whilst it has been shown that the accuracy of RDTs
is comparable to that of expert microscopy [33,34],
unless CHWs appreciate the ease and reliability of
RDTs, uptake and correct usage may remain low, and
over-prescription rates may remain similar to those
seen when using microscopy [5,9,35-37]. It is thus
promising that CHWs expressed an appreciation of the
simplicity, rapidness and portability of RDTs over mi-
croscopy as well as acknowledging the large bonus of
not being dependant on an electricity supply. Whilst
all HFs in this study had the equipment and facilities
required to carry out diagnosis by microscopy the avail-
ability of this service would depend on whether or not
the laboratory technician was available. The negative
comments pertaining to RDTs related to the perceived
advantages of microscopy and the familiarity CHWs
feel towards it and the added benefits of more informa-
tion about parasitic load. The issue of familiarity is one
which time and continued RDT use and support and
training will address. As for the issue of not being able
to measure parasitic loads, this should not be a barrier
to RDT use with patients presenting at health facilities.
Passive case detection such as carried out in this study
relies on patients feeling ill enough to go to a HF and
seek diagnosis and treatment. This usually means that
the patient has a parasite load high enough so that
RDTs can be relied upon to pick up infection. This may
not always be the case when actively looking for malaria
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infections, some of which may have very low parasite
densities. All RDT-positive patients require treatment and
the measurement of parasitic load is irrelevant in these
cases. The message of RDT positive being the principle
guide to treatment must be relayed in a clear manner to
HCWs and patients.
The issue of acceptability of negative RDTs is one of
high importance amongst both community members
and HCWs. There has been a long history in Kenya, as
in much of Africa, of prescribing anti-malarials on the
assumption that most headaches, joint pains and fevers
are due to malaria infection [38-40]. The universal test
and treat strategy of today is a significant change from
previous WHO guidelines recommending presumptive
treatment of all suspected cases of malaria; with this
recommendation in place until recently it is unsurprising
that the prescription of anti-malarials in the absence of a
confirmatory diagnosis has long been the norm and
continues to be in many areas and HFs [40]. However,
as malaria prevalence continues to decrease, the propor-
tion of fevers attributable to a cause other than malaria
increases; diagnosis based solely on clinical symptoms
alone is not efficient, cost-effective or ethical [11,38]. In
the case of this study, community members report not
believing RDTs if they are negative, as they perceive their
symptoms alone as confirmation of malaria. This high-
lights a key shortcoming of RDTs and their ability to only
exclude or confirm the presence of malaria parasites, leav-
ing the patient with no more information as to what may
be causing their symptoms. Upon a negative RDT result
there is great dichotomy between patients who want anti-
malarials to alleviate their joint aches, as they know they
do from previous experience, and clinicians who want to
determine the real cause of symptoms but are not able to
do so without other diagnostic tests. The vertical nature of
RDTs and the lack of availability of other diagnostic tests
in areas where malaria prevalence is low and many other
infectious diseases co-exist, acts as a barrier to uptake and
acceptability of RDTs as patients and clinicians alike are
unable to treat the true cause of the symptoms.
Reporting from both CHWs and patients of suspicion
towards the reliability of negative RDTs highlights the
need for some form of reassurance for HCW and patient
alike. Novel tools such as Positive Control Wells allow
for rapid evaluation of RDT performance without the
need for cross-checking against expert microscopy,
potentially to increasing the confidence of clinicians in
the quality of RDTs and encouraging confident man-
agement of symptoms according to RDT result [41].
Whilst additional tests, such as these, may provide solid
proof of the validity of RDT results they may also just
present another tool around which suspicion builds.
Probably more suitable and logistically feasible in the
setting of this study are the ongoing efforts to educate
and encourage CHWs in their trust of RDT results and
training in passing this information on to the patient.
HCWs who are competent in the use of RDTs and trust
the result given should prepare patients for negative
results and reassure them that they do not mean the
patient will go untreated for the true cause of their
symptoms. In areas such as the study setting of Garissa
County where transmission is highly seasonal and malaria
incidence low over most of the year, this emphasis is of
particular importance as the proportion of negative
RDTs would be expected to be high.
A highly important point raised by CHWs and related
to all the issues discussed thus far is the problem of
availability and supply of RDTs. CHWs reported RDTs
not being consistently available in the quantities needed.
If CHWs are not able to consistently offer RDTs to
patients the task of familiarizing patients with RDTs and
educating them as to their importance becomes infin-
itely harder, despite the best efforts of CHWs. Thus the
issue of availability is tightly linked to the issue of educa-
tion and, in turn, RDT uptake and correct usage. It is of
concern that this issue was raised by CHWs in this rela-
tively small study area of Greater Garissa; whilst the fre-
quency of stock-outs was greatly reduced during this
study period they evidently still occurred often enough
to be reported by CHWs. If supply chain issues already
exist within this study area of just one county, they are
likely to be an even greater challenge when working
towards national scale up of RDTs across the whole
country. The availability of sufficient supplies of ACT is
highly pertinent to this point as the use of RDTs is only
logical should ACT then be available for prescription to
positive cases. In many public and private HFs in Kenya
the availability of affordable ACT cannot be relied upon
and has been shown to have been a significant factor in
influencing patterns of anti-malarial use [42-45]. Secur-
ing and backing up the supply chains of both RDTs and
ACT should be a priority in any national programme in
order to sustain the trust and proper use of RDTs and
ACT amongst CHWs and patients alike.
Limitations
With the aim of extrapolating study results to other
counties of Kenya and informing the national roll-out of
RDTs, the main limitation to this study arises due to the
study area being just one county. Whilst the HFs, HCWs
and community members involved in this study are un-
likely to be drastically different from their counterparts
in other counties, appreciation of potential differences,
and thus potential limitations to the generalizability of
the data, is important. It is not unfeasible that the polit-
ical history and current day security setting of Greater
Garissa have had an impact on both the general capacity
and functioning of HFs in the county, the health-seeking
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behaviours of patients, and the quality and consistency of
health care provided by HCWs. Any or all of these could
have an impact on RDT uptake and correct usage in ways
that may not be seen in other counties. Changes in the
epidemiology of malaria between, and within, counties are
likely to pose another limitation to the use of these results.
For example, in the southwest of Kenya, surrounding Lake
Victoria, where malaria endemicity is ranked greater than
40%, the proportion of negative RDTs will be much smaller
than seen in Greater Garissa. This may well change the
knowledge and perceptions of HCWs and patients towards
malaria and RDTs. Limitations may also arise due to the
qualitative research methods used; whilst study participants
were not told the research question or the purpose of the
study, it is plausible that their answers and opinions may
have been affected by one of many types of bias.
Conclusions
Misconceptions and incomplete knowledge about malaria
transmission and prevention contribute to the under-
utilization and misuse of available RDTs. The diagnosis of
malaria has changed so drastically in Garissa over the last
50 years; from all fevers being presumed to be malaria to
the current requirement of confirmatory diagnosis, that it
is unsurprising that despite some understanding of the
transmission, prevention, diagnosis and treatment of
malaria, gaps in knowledge and incorrect beliefs still
exist and may act as barriers to accurate malaria diagnosis
and correct case management. Addressing these barriers
to uptake and correct usage requires comprehensive and
ongoing education campaigns for both providers and
communities, which in turn necessitate a reliable and con-
sistent RDT supply. The results of this study highlight
education and the supply chain as key factors to be
addressed in order to make national scale-up of RDTs as
successful as possible. Emphasis should also be placed on
the need for diagnostic tests for other causes of illness
amongst patients in order to strengthen the entire health
system and not just malaria case management. Based on
the findings of this study it is recommended that NGOs
and national malaria programmes are used to reinforce
education for communities regarding malaria misconcep-
tions, improving access to health care at more peripheral
levels, education and ongoing refresher programmes for
CHWs, and private and public partnership to improve
access to diagnostic methods and treatment. Along with
these local interventions, it is also recommended that
transnational approaches to secure a consistent and reli-
able supply of RDTs is made a priority. This study high-
lights the many factors which must be considered when
striving to achieve both correct case management of
accurately diagnosed malaria and a well functioning health
care system which patients can rely on, whether they have
malaria or not.
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